Agios Pharmaceuticals: 4Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $97.7 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.41.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of $1.41 per share.
The biopharmaceutical company posted revenue of $44 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $36.3 million.
For the year, the company reported that its loss narrowed to $327.4 million, or $4.74 per share. Revenue was reported as $203.2 million.
Agios Pharmaceuticals shares have increased 22% since the beginning of the year. The stock has climbed 6.5% in the last 12 months.